Chemical Component Summary

NameN-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide
SynonymsAnagliptin
IdentifiersN-[2-[[2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxidanylidene-ethyl]amino]-2-methyl-propyl]-2-methyl-pyrazolo[1,5-a]pyrimidine-6-carboxamide
FormulaC19 H25 N7 O2
Molecular Weight383.448
TypeNON-POLYMER
Isomeric SMILESCc1cc2ncc(cn2n1)C(=O)NCC(C)(C)NCC(=O)N3CCC[C@H]3C#N
InChIInChI=1S/C19H25N7O2/c1-13-7-16-21-9-14(11-26(16)24-13)18(28)22-12-19(2,3)23-10-17(27)25-6-4-5-15(25)8-20/h7,9,11,15,23H,4-6,10,12H2,1-3H3,(H,22,28)/t15-/m0/s1
InChIKeyLDXYBEHACFJIEL-HNNXBMFYSA-N

Chemical Details

Formal Charge0
Atom Count53
Chiral Atom Count1
Bond Count55
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB12417 
NameAnagliptin
Groups investigational
DescriptionAnagliptin is under investigation for the treatment of LDL Cholesterol, Coronary Disease, Diabetes Mellitus, Glycosylated Hemoglobin, and Dipeptidyl-Peptidase 4 Inhibitors.
SynonymsAnagliptin
Categories
  • Agents causing angioedema
  • Blood Glucose Lowering Agents
  • DPP-IV Inhibitors
  • Enzyme Inhibitors
  • Protease Inhibitors
CAS number739366-20-2

Related Resource References

Resource NameReference
PubChem 44513473
ChEMBL CHEMBL1929396
ChEBI CHEBI:136043
CCDC/CSD KAKGUB